Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Flavell

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response elementInés Pineda Torra, Yalda Jamshidi, David M Flavell, et al.
Biochemical and Biophysical Research Communications|July 13, 2007
IP receptor-dependent activation of PPARgamma by stable prostacyclin analoguesEmilia Falcetti, David M Flavell, Bart Staels, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 19, 2006
Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise trainingPeter T E Wootton, David M Flavell, Hugh E Montgomery, et al.
Diabetes|January 29, 2005
Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetesDavid M Flavell, Helen Ireland, Jeffrey W Stephens, et al.
Human Molecular Genetics|June 4, 2004
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study IIWendy Putt, Jutta Palmen, Viviane Nicaud, et al.
The Journal of Physiology|June 19, 2003
Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neuronesSara E Wells, David M Flavell, Gordon W Bisset, et al.
Molecular Genetics and Metabolism|December 7, 2002
Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemiaPetra M H Eurlings, Carla J H van der Kallen, Jan M W Geurts, et al.
BMC Genetics|November 14, 2002
Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weightAlex Doney, Bettina Fischer, David Frew, et al.
Clinical Science (London, England : 1979)|February 13, 2007
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart diseasePhilippa J Talmud, David M Flavell, Khaled Alfakih, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2006
Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growthDavid M Flavell, Peter T E Wootton, Saul G Myerson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response elementInés Pineda Torra, Yalda Jamshidi, David M Flavell, et al.
Biochemical and Biophysical Research Communications|July 13, 2007
IP receptor-dependent activation of PPARgamma by stable prostacyclin analoguesEmilia Falcetti, David M Flavell, Bart Staels, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 19, 2006
Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise trainingPeter T E Wootton, David M Flavell, Hugh E Montgomery, et al.
Diabetes|January 29, 2005
Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetesDavid M Flavell, Helen Ireland, Jeffrey W Stephens, et al.
Human Molecular Genetics|June 4, 2004
Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study IIWendy Putt, Jutta Palmen, Viviane Nicaud, et al.
The Journal of Physiology|June 19, 2003
Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neuronesSara E Wells, David M Flavell, Gordon W Bisset, et al.
Molecular Genetics and Metabolism|December 7, 2002
Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemiaPetra M H Eurlings, Carla J H van der Kallen, Jan M W Geurts, et al.
BMC Genetics|November 14, 2002
Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weightAlex Doney, Bettina Fischer, David Frew, et al.
Clinical Science (London, England : 1979)|February 13, 2007
The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart diseasePhilippa J Talmud, David M Flavell, Khaled Alfakih, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2006
Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growthDavid M Flavell, Peter T E Wootton, Saul G Myerson, et al.
Pageof 2